CAPORALI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 9.376
AS - Asia 7.527
EU - Europa 6.140
SA - Sud America 926
AF - Africa 86
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.075
Nazione #
US - Stati Uniti d'America 9.185
CN - Cina 4.442
IE - Irlanda 1.573
SG - Singapore 1.539
UA - Ucraina 909
HK - Hong Kong 845
FI - Finlandia 834
BR - Brasile 782
DE - Germania 715
RU - Federazione Russa 713
SE - Svezia 450
IT - Italia 329
VN - Vietnam 288
GB - Regno Unito 264
CA - Canada 124
FR - Francia 94
IN - India 85
AR - Argentina 53
JP - Giappone 52
TR - Turchia 47
BD - Bangladesh 44
AT - Austria 43
PL - Polonia 39
MX - Messico 36
IQ - Iraq 33
ZA - Sudafrica 30
ES - Italia 29
ID - Indonesia 29
BE - Belgio 28
CZ - Repubblica Ceca 28
EC - Ecuador 27
NL - Olanda 24
PK - Pakistan 15
VE - Venezuela 14
CO - Colombia 13
IR - Iran 13
SA - Arabia Saudita 13
CL - Cile 12
IL - Israele 12
AU - Australia 11
MA - Marocco 11
DO - Repubblica Dominicana 10
LT - Lituania 10
UY - Uruguay 10
TN - Tunisia 9
PE - Perù 8
HU - Ungheria 7
DZ - Algeria 6
KG - Kirghizistan 6
LV - Lettonia 6
RO - Romania 6
AL - Albania 5
AZ - Azerbaigian 5
CR - Costa Rica 5
EG - Egitto 5
JO - Giordania 5
KR - Corea 5
MU - Mauritius 5
NP - Nepal 5
NZ - Nuova Zelanda 5
SY - Repubblica araba siriana 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
EU - Europa 4
GR - Grecia 4
KZ - Kazakistan 4
PY - Paraguay 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
EE - Estonia 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
GY - Guiana 2
HR - Croazia 2
LB - Libano 2
MM - Myanmar 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TJ - Tagikistan 2
ZM - Zambia 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
Totale 24.055
Città #
Dublin 1.570
Chandler 1.470
Jacksonville 1.280
Nanjing 1.066
Hong Kong 843
Ashburn 704
Dallas 700
Beijing 618
Singapore 604
Boardman 480
Nanchang 426
Princeton 359
Lawrence 327
Wilmington 320
Changsha 310
Shenyang 308
Hebei 304
Helsinki 267
Medford 245
Los Angeles 243
Jiaxing 231
Tianjin 175
Hangzhou 174
Ann Arbor 161
Munich 150
Moscow 126
Redondo Beach 124
New York 119
Shanghai 114
Ho Chi Minh City 111
Buffalo 107
Milan 96
Woodbridge 80
São Paulo 69
Pavia 68
Norwalk 65
Hanoi 58
Toronto 52
Turku 50
Seattle 49
Verona 48
Tokyo 42
Brooklyn 39
Chicago 38
Warsaw 36
Fairfield 35
Falkenstein 34
San Francisco 31
Brussels 28
London 28
Montreal 28
The Dalles 27
Vienna 27
Boston 26
Guangzhou 25
Houston 25
Jinan 25
Santa Clara 25
Zhengzhou 24
Stockholm 22
Phoenix 21
Washington 21
Ankara 20
Kunming 20
Atlanta 19
Brno 19
Chennai 19
Denver 19
Ningbo 19
Rio de Janeiro 19
Columbus 17
Johannesburg 17
Porto Alegre 17
Belo Horizonte 16
Brasília 16
Des Moines 15
Manchester 15
Orem 15
Auburn Hills 14
Haiphong 14
Nuremberg 14
Orange 14
Poplar 14
Pune 14
Secaucus 14
Taizhou 14
Lanzhou 12
Mexico City 12
Amsterdam 11
Biên Hòa 11
Falls Church 11
Guayaquil 10
Betim 9
Changchun 9
Chongqing 9
Curitiba 9
Dhaka 9
Fuzhou 9
Hefei 9
Montevideo 9
Totale 15.811
Nome #
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 160
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. 132
B cells in rheumatoid arthritis. 122
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 121
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 121
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 121
DMARDS and infections in rheumatoid arthritis 117
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 117
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 116
A case of adult onset Still's disease treated with infliximab - Reply 114
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 112
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 109
Shrinking lung syndrome in sistemic sclerosis 109
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. 108
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 108
Analysis of Human Myeloma Cell-population Kinetics 108
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 107
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 107
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 106
Interessamento cutaneo nella dermatomiosite 105
Antibodies to cyclic citrullinated peptides in psoriatic arthritis. 105
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 105
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 105
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 104
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 104
B cells in rheumatoid arthritis. 104
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 103
Disease-related malnutrition in systemic sclerosis: Evidences and implications 103
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 102
Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients 101
Diffuse skin reaction after changing the etanercept formulation 101
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 101
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 101
Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis 101
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 100
Analysis of pharmacologic and nonpharmacologic prescription patterns of general practitioners and specialists in the AMICA study. 100
Association between anti-dsDNA titre increase and thymoma relapse 99
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases 99
Influenza may influence rheumatoid arthritis 98
TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. 98
null 97
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal 97
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 97
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 97
Mature antigen-experienced helper T cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of rheumatoid joint 97
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 96
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 96
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 95
Fetal programming and systemic sclerosis 95
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 93
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 93
Cyclophosphamide plus granulocyte colony stimulating factor (G-CSF) is more 92
Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease 92
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects]. 92
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis. 91
[New classification criteria for rheumatoid arthritis]. 91
Biosimilars: Lights and shadows in rheumatology 91
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 91
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis 91
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 90
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 90
Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response 90
Spondiliti e spondilodisciti batteriche. 89
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 89
Prednisone plus Methotrexate for polymyalgia rheumatica. A randomized, double blind, placebo-controlled trial. 89
Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of wong's dermatomyositis 89
Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis 88
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 88
Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes 88
Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry 88
Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria 87
Iron Status In Stills Disease 87
Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis 87
A Seasonal Pattern In the Onset of Polymyalgia Rheumatica 87
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. 86
Diffuse skin reaction after changing the etanercept formulation. Clin Exp Rheumatol. 86
Efficacy and safety of anti-TNF agents in the Lombardy Rheumatoid Arthritis Network (LORHEN) 86
Glucocorticoids in rheumatoid arthritis 86
Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical 85
Safety of Mud-Bath Applications in Moderately Active Rheumatoid Arthritis 85
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 85
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis 85
Connective tissue diseases and autoimmune thyroid disorders in the first trimester of pregnancy 85
Uterine artery Doppler velocimetry and obstetric outcomes in connective tissue diseases diagnosed during the first trimester of pregnancy. 85
Autoimmunity in thrombotic thrombocytopenic purpura 84
Nuovi aspetti patogenetici dell’artrite reumatoide 84
Rheumatoid arthritis in beta-thalassaemia trait 84
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 84
The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome 84
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 84
Safety of Tumor Necrosis Factor alpha Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative/Anti-Hepatitis B Core Antigen Positive) With Rheumatic Diseases 83
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 83
Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association? 83
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. 82
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 82
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs 82
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 82
La terapia delle vasculiti necrotizzanti 81
Pulmonary arterial hypertension in antisynthetase syndrome: comment on the article by Chatterjee and Farver. 81
Overuse of prescription and otc non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis. 81
Totale 9.642
Categoria #
all - tutte 113.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.250 0 0 0 0 0 249 19 292 82 305 234 69
2021/20221.349 31 6 32 14 18 38 44 99 66 20 207 774
2022/20234.426 532 295 37 266 465 466 2 260 1.875 33 116 79
2023/20241.517 169 339 63 115 156 381 16 98 10 49 47 74
2024/20254.179 100 371 96 114 50 175 159 312 1.032 131 458 1.181
2025/20264.884 784 706 1.184 1.017 1.096 97 0 0 0 0 0 0
Totale 24.589